Table of contents
In this issue
p699 | doi:10.1038/nrd1844
Editorial: One world problem, one world solution?
p701 | doi:10.1038/nrd1843
News and Analysis
Tysabri risk causing headache for companies | PDF (85 KB)
p703 | doi:10.1038/nrd1837
Europe fiddles while innovation burns | PDF (90 KB)
p704 | doi:10.1038/nrd1838
Acquisitions not a cure for antiinfectives | PDF (92 KB)
p704 | doi:10.1038/nrd1839
News in Brief
Patent watch
Baffled by claim construction | PDF (87 KB)
p708 | doi:10.1038/nrd1841
Patent watch
'Optional' ingredients anticipate | PDF (61 KB)
p708 | doi:10.1038/nrd1842
Patent primer
Maximizing exclusivity for drug products | PDF (83 KB)
p709 | doi:10.1038/nrd1829
Career Path
Paul L. Herrling | PDF (88 KB)
p710 | doi:10.1038/nrd1836
From the analyst's couch
Wet age-related macular degeneration | PDF (173 KB)
p711 | doi:10.1038/nrd1827
Fresh from the Pipeline
Exenatide | PDF (184 KB)
p713 | doi:10.1038/nrd1828
Research Highlights
Biologics: Break it up | PDF (230 KB)
p715 | doi:10.1038/nrd1835
Anticancer drugs: Double strike | PDF (169 KB)
p716 | doi:10.1038/nrd1832
HIV-1: Viral assembly inhibitors on the horizon | PDF (355 KB)
p716 | doi:10.1038/nrd1834
RNA interference: Knocked down for the count | PDF (268 KB)
p717 | doi:10.1038/nrd1833
Infectious disease: Unravelling SARS lethality | PDF (149 KB)
p718 | doi:10.1038/nrd1830
In brief
Alzheimer's disease | Anti-thrombotics | Inflammation | PDF (149 KB)
p718 | doi:10.1038/nrd1831
Perspectives
Outlook
Directed development: catalysing a global biotech industry
Anthony Sun & Tom Perkins
p719 | doi:10.1038/nrd1826
Reviews
Opportunities and Challenges in Antiparasitic Drug Discovery
Richard Pink, Alan Hudson, Marie-Annick Mouriès & Mary Bendig
p727 | doi:10.1038/nrd1824
Can we Develop Neurally Acting Drugs for the Treatment of Migraine?
Peter J. Goadsby
p741 | doi:10.1038/nrd1822
Automated synthesis of oligosaccharides as a basis for drug discovery
Peter H. Seeberger & Daniel B. Werz
p751 | doi:10.1038/nrd1823
Article series: Case Histories
Case history
The Discovery of Fluoxetine Hydrochloride (Prozac)
David T. Wong, Kenneth W. Perry & Frank P. Bymaster
p764 | doi:10.1038/nrd1821
Article series: Model organisms
Model organisms: The ascent of mouse: advances in modelling human depression and anxiety
John F. Cryan & Andrew Holmes
p775 | doi:10.1038/nrd1825
